COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and significantly affect patient quality of life and socioeconomic status. Numerous reports consistently demonstrate that CVDs are a major risk factor for severe course of coronavirus disease 2019 (COVID-19), including higher...
Saved in:
| Main Authors: | S. S. Bunova, P. I. Okhotnikova, Yu. P. Skirdenko, N. A. Nikolaev, O. A. Osipova, N. I. zhernakova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-07-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)
by: G. P. Arutyunov, et al.
Published: (2021-04-01) -
Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
by: A. R. Tyapaeva, et al.
Published: (2022-02-01) -
Is anticoagulant therapy necessary after hospitalization with COVID-19 pneumonia?
by: P. A. Davtyan, et al.
Published: (2022-02-01) -
Russian vaccines against COVID-19: their characteristics, efficacy and safety
by: A. E. Bilev, et al.
Published: (2023-01-01) -
Predictive value of the Elixhauser comorbidity index in assessing the risk of coronavirus disease (COVID-19) mortality in patients with pneumonia
by: I. O. Kuliesh, et al.
Published: (2025-02-01)